KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxlinear (MXL) Shares Issued (2016 - 2025)

Maxlinear (MXL) has disclosed Shares Issued for 16 consecutive years, with $1.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Issued fell 44.63% to $1.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.9 million, a 3.94% decrease, with the full-year FY2025 number at $3.6 million, down 13.03% from a year prior.
  • Shares Issued was $1.4 million for Q4 2025 at Maxlinear, up from $27000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $4.8 million in Q2 2021 to a low of $3000.0 in Q1 2023.
  • A 5-year average of $1.5 million and a median of $1.4 million in 2023 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: surged 165.98% in 2021, then crashed 96.55% in 2023.
  • Maxlinear's Shares Issued stood at $2.5 million in 2021, then decreased by 28.15% to $1.8 million in 2022, then dropped by 22.38% to $1.4 million in 2023, then skyrocketed by 80.59% to $2.5 million in 2024, then tumbled by 44.63% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for MXL's Shares Issued are $1.4 million (Q4 2025), $27000.0 (Q3 2025), and $2.5 million (Q4 2024).